Global Travelers Vaccines Market Size By Type (Meningococcal Vaccine, Japanese Encephalitis Vaccine), By Application (Tourists, Students, Workers), By Geographic Scope And Forecast
Published on: 2024-08-07 | No of Pages : 320 | Industry : latest updates trending Report
Publisher : MIR | Format : PDF&Excel
Global Travelers Vaccines Market Size By Type (Meningococcal Vaccine, Japanese Encephalitis Vaccine), By Application (Tourists, Students, Workers), By Geographic Scope And Forecast
Travelers Vaccines Market Size And Forecast
Travelers Vaccines Market size is growing at a moderate pace with substantial growth rates over the last few years and is estimated that the market will grow significantly in the forecasted period i.e. 2023 to 2030.
Increased incidence of travel-related diseases is expected to drive market growth. Traveling is generally associated with elevated health risks, especially with regard to infectious diseases. Thus, the rising incidence of travel-related diseases will lead to more investments in the Global Travelers Vaccines Market for the development of more effective vaccines. The Global Travelers Vaccines Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.
Global Travelers Vaccines Market Definition
Travel vaccines, also known as travel immunizations, are vaccines travelers can get before they visit certain regions across the globe which help protect them from serious diseases. Travel vaccines function by exposing the body to a microorganism or parts of the microorganism of disease that it will have protection against. The body responds to the vaccination by creating antibodies that will be protecting it against a situation where there is exposure to the disease in the future. Vaccines are biological-based formulations that are innovated mainly to combat specific diseases, by bolstering the immunity system of patients. Vaccines comprise agents comparable to the target organism, made from the killed or attenuated form of the microbe. The efficacy of vaccine formulations highly depends on the vaccine strain, the vaccine schedule, the pathophysiology of the disease, and genetic predisposition.
Vaccines are the integration of killed microorganisms, living attenuated organisms, or living fully virulent organisms that are being monitored for artificially increasing or creating immunity for certain diseases. The medicine branch which deals with the prevention and management of health issues of international travelers is called Emporiatrics. The first step towards smart and healthy travel is the travel vaccine. These days along with the passport, having travel vaccine shots are mandatory before a person embarks on international travel. Such vaccines give immunization by lowering the risk of getting sick while traveling abroad.
Tourists traveling to South America as well as central countries of Africa should consider getting vaccinated for Yellow Fever. Similarly, different countries are having different diseases existing or prevailing within the region. Travel vaccines are suggested by various health organizations, especially to tourists who are traveling to developing or endemic countries. DUKORAL is an example of a travel vaccine that provides protection to tourists from Diarrhea and Cholera. These are the regular diseases caused by the ingestion of contaminated food and water while traveling. Travel vaccine shot recommendations differ for each person depending on the gender, age, and medical history of the tourist.
Global Travelers Vaccines Market Overview
The number of international tourist arrivals increased across the globe from 1.0 Billion in 2012 to close to 1.4 Billion in 2019. A significant number of these travelers journey from developed countries to regions with endemic diseases. Due to several people’s travel to countries having endemic diseases, there is a continuous increase in demand for vaccines. Moreover, regulatory authorities across the globe have also mandated that travelers should be vaccinated before traveling to disease-prone regions. As a result, travel vaccines have now become an important requirement in the international traveler’s list.
With the rising trend of globalization, international travel activities have increased astronomically in the past years, which resulted in the generation of significant demand for travel vaccines. Many infectious disease vaccines are specific to the region and have been carried out with geography-specific immunization. Increased traveling in the past few years has resulted in the spread of pathogens and disease-causing vectors globally. The increase in travel and migration provides many opportunities for manufacturers to doing investments in the R&D of novel and more improved vaccines.
Innovations in new vaccine technologies and technological advancements related to molecular genetics are bound to boost the growth of the market in the future. Furthermore, a shortage of an adequately trained workforce for vaccine production and a lack of proper healthcare infrastructure can restrain the market. The covid-19 outbreak is expected to generate limited disruptions, owing to the high demand for a vaccine for the covid-19 virus. The extraordinary investments are done for research and development from private and public bodies will surely create an impact on the Travelers Vaccines Market.
Global Travelers Vaccines MarketSegmentation Analysis
The Global Travelers Vaccines Market is Segmented on the basis of Type, Application, and Geography.
Travelers Vaccines Market, By Type
- Meningococcal Vaccine
- Japanese Encephalitis Vaccine
- Yellow Fever Vaccine
- Hepatitis Vaccine
- Other
Based on Type, the market is segmented into Meningococcal Vaccine, Japanese Encephalitis Vaccine, Yellow Fever Vaccine, Hepatitis Vaccine, and Other. Among all the types of vaccines available for different diseases. The Hepatitis A vaccine represents the largest disease, dominating the market. It is a viral disease that can be transmitted through direct contact with an infectious person or the consumption of contaminated food and water. The demand of the vaccine is directly related to the severity of a disease can cause.
Travelers Vaccines Market, By Application
- Tourists
- Students
- Workers
- Others
Based on Application, the market is segmented into Tourists, Students, Workers, and Others. There are four types of applications for traveler vaccines. Each one of them is equally important for the growth of the economy. Usually, frequent tourists dominate the market. Nowadays the demand for studying in a developed country is also increasing leading to the increased need for travel vaccines for the student of developing countries students. The increased employment opportunities globally are also forcing people to migrate to different countries for work purposing hence fuelling the need of the market.
Travelers Vaccines Market, By Geography
- North America
- Europe
- Asia Pacific
- Rest of the world
On the basis of Geography, The Global Travelers Vaccines Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America is the leader of the Global Travelers Vaccines Market. A large number of companies in that region are introducing a superior range of travel vaccines, including a vaccine against Varicella. It is expected that the market will continue to be ruled by North America in the forecast period.
Key Players
The “Global Travelers Vaccines Market” study report will provide valuable insight with an emphasis on the global market. The major players in the market are CSL Limited, Pfizer Inc., AstraZeneca PLC, Abbott Laboratories, Sanofi Pasteur, Novartis AG, ALK-Abello A/S, Curcell, Altimmune, Inc., and Merck & Co., Inc. The report provides a detailed analysis of each player in the market. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.
Report Scope
REPORT ATTRIBUTES | DETAILS |
---|---|
STUDY PERIOD | 2019-2030 |
BASE YEAR | 2022 |
FORECAST PERIOD | 2023-2030 |
HISTORICAL PERIOD | 2019-2021 |
KEY COMPANIES PROFILED | CSL Limited, Pfizer Inc., AstraZeneca PLC, Abbott Laboratories, Sanofi Pasteur, Novartis AG, ALK-Abello A/S, Curcell, Altimmune, Inc., and Merck & Co., Inc. |
SEGMENTS COVERED |
|
CUSTOMIZATION SCOPE | Free report customization (equivalent to up to 4 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope |
Top Trending Reports
Research Methodology of Market Research
To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .
Reasons to Purchase this Report
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post-sales analyst support
Customization of the Report
• In case of any please connect with our sales team, who will ensure that your requirements are met.